Integrating age and comorbidity to assess screening mammography utilization

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Most studies use age as a cutoff to evaluate screening mammography utilization, generally examining screening up to age 75 years (the age-cutoff method). However, many experts and guidelines encourage clinicians to consider patient health and/or life expectancy. Purpose: To compare the accuracy of estimating screening mammography utilization in older women using the age-cutoff method versus using a method based on the projected life expectancy. Methods: Two cohorts were selected from female Medicare beneficiaries aged 6790 years living in Texas in 2001 and 2006. The 2001 cohort (n=716,279) was used to generate life-expectancy estimates by age and comorbidity, which were then applied to the 2006 cohort (n=697,825). Screening mammography utilization during 20062007 was measured for the 2006 cohort. Data were collected in 20002007 and analyzed in 2011. Results: The screening rate was 52.7% in women aged 6774 years based on age alone, compared to 53.5% in women in the same age group with a life expectancy of <7 years. A large proportion (63.4%) of women aged 7590 years (n=370,583) had a life expectancy of <7 years. Those women had a screening rate of 42.7%. The screening rate was 35.7% in women aged 7590 years based on age alone, compared to 16.3% in women in the same age group with a life expectancy of <5 years. Conclusions: Estimating screening mammography utilization among older women can be improved by using projected life expectancy rather than the age-cutoff method.

Original languageEnglish (US)
Pages (from-to)229-234
Number of pages6
JournalAmerican Journal of Preventive Medicine
Volume42
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Mammography
Life Expectancy
Comorbidity
Age Groups
Medicare
Guidelines
Health

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Integrating age and comorbidity to assess screening mammography utilization. / Tan, Alai; Kuo, Yong Fang; Goodwin, James.

In: American Journal of Preventive Medicine, Vol. 42, No. 3, 03.2012, p. 229-234.

Research output: Contribution to journalArticle

@article{7a0a65a0c88d41c69586b2e0fb793e88,
title = "Integrating age and comorbidity to assess screening mammography utilization",
abstract = "Background: Most studies use age as a cutoff to evaluate screening mammography utilization, generally examining screening up to age 75 years (the age-cutoff method). However, many experts and guidelines encourage clinicians to consider patient health and/or life expectancy. Purpose: To compare the accuracy of estimating screening mammography utilization in older women using the age-cutoff method versus using a method based on the projected life expectancy. Methods: Two cohorts were selected from female Medicare beneficiaries aged 6790 years living in Texas in 2001 and 2006. The 2001 cohort (n=716,279) was used to generate life-expectancy estimates by age and comorbidity, which were then applied to the 2006 cohort (n=697,825). Screening mammography utilization during 20062007 was measured for the 2006 cohort. Data were collected in 20002007 and analyzed in 2011. Results: The screening rate was 52.7{\%} in women aged 6774 years based on age alone, compared to 53.5{\%} in women in the same age group with a life expectancy of <7 years. A large proportion (63.4{\%}) of women aged 7590 years (n=370,583) had a life expectancy of <7 years. Those women had a screening rate of 42.7{\%}. The screening rate was 35.7{\%} in women aged 7590 years based on age alone, compared to 16.3{\%} in women in the same age group with a life expectancy of <5 years. Conclusions: Estimating screening mammography utilization among older women can be improved by using projected life expectancy rather than the age-cutoff method.",
author = "Alai Tan and Kuo, {Yong Fang} and James Goodwin",
year = "2012",
month = "3",
doi = "10.1016/j.amepre.2011.11.008",
language = "English (US)",
volume = "42",
pages = "229--234",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Integrating age and comorbidity to assess screening mammography utilization

AU - Tan, Alai

AU - Kuo, Yong Fang

AU - Goodwin, James

PY - 2012/3

Y1 - 2012/3

N2 - Background: Most studies use age as a cutoff to evaluate screening mammography utilization, generally examining screening up to age 75 years (the age-cutoff method). However, many experts and guidelines encourage clinicians to consider patient health and/or life expectancy. Purpose: To compare the accuracy of estimating screening mammography utilization in older women using the age-cutoff method versus using a method based on the projected life expectancy. Methods: Two cohorts were selected from female Medicare beneficiaries aged 6790 years living in Texas in 2001 and 2006. The 2001 cohort (n=716,279) was used to generate life-expectancy estimates by age and comorbidity, which were then applied to the 2006 cohort (n=697,825). Screening mammography utilization during 20062007 was measured for the 2006 cohort. Data were collected in 20002007 and analyzed in 2011. Results: The screening rate was 52.7% in women aged 6774 years based on age alone, compared to 53.5% in women in the same age group with a life expectancy of <7 years. A large proportion (63.4%) of women aged 7590 years (n=370,583) had a life expectancy of <7 years. Those women had a screening rate of 42.7%. The screening rate was 35.7% in women aged 7590 years based on age alone, compared to 16.3% in women in the same age group with a life expectancy of <5 years. Conclusions: Estimating screening mammography utilization among older women can be improved by using projected life expectancy rather than the age-cutoff method.

AB - Background: Most studies use age as a cutoff to evaluate screening mammography utilization, generally examining screening up to age 75 years (the age-cutoff method). However, many experts and guidelines encourage clinicians to consider patient health and/or life expectancy. Purpose: To compare the accuracy of estimating screening mammography utilization in older women using the age-cutoff method versus using a method based on the projected life expectancy. Methods: Two cohorts were selected from female Medicare beneficiaries aged 6790 years living in Texas in 2001 and 2006. The 2001 cohort (n=716,279) was used to generate life-expectancy estimates by age and comorbidity, which were then applied to the 2006 cohort (n=697,825). Screening mammography utilization during 20062007 was measured for the 2006 cohort. Data were collected in 20002007 and analyzed in 2011. Results: The screening rate was 52.7% in women aged 6774 years based on age alone, compared to 53.5% in women in the same age group with a life expectancy of <7 years. A large proportion (63.4%) of women aged 7590 years (n=370,583) had a life expectancy of <7 years. Those women had a screening rate of 42.7%. The screening rate was 35.7% in women aged 7590 years based on age alone, compared to 16.3% in women in the same age group with a life expectancy of <5 years. Conclusions: Estimating screening mammography utilization among older women can be improved by using projected life expectancy rather than the age-cutoff method.

UR - http://www.scopus.com/inward/record.url?scp=84857216921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857216921&partnerID=8YFLogxK

U2 - 10.1016/j.amepre.2011.11.008

DO - 10.1016/j.amepre.2011.11.008

M3 - Article

C2 - 22341159

AN - SCOPUS:84857216921

VL - 42

SP - 229

EP - 234

JO - American Journal of Preventive Medicine

JF - American Journal of Preventive Medicine

SN - 0749-3797

IS - 3

ER -